Nasdaq IPO – The Milli Chronicle

Friday, December 12, 2025

Latest:

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle December 11, 2025 aging population health, AI in healthcare, chronic disease diagnostics, CT scans, diagnostic imaging, healthcare expansion, healthcare innovation, healthcare investments, healthcare technology, imaging centers, imaging technology, investor confidence, Lumexa Imaging, medical imaging market, medical services demand, MRI services, Nasdaq IPO, radiology growth, U.S. healthcare trends, U.S. IPO market

Lumexa Imaging makes confident Nasdaq debut with $1.76 billion valuation

Strong investor interest and rising demand for advanced diagnostic imaging push Lumexa Imaging into the spotlight as one of the

Featured Lifestyle Technology

NewsDesk Milli Chronicle October 4, 2025 1789 Capital, AI chip market, AI chips, AI funding news, AI hardware innovation, AI industry trends, AI innovation news, AI investor confidence, AI market growth, AI R&D investment, AI semiconductor, AI startup news, AI systems expansion, AI technology growth, AI technology leadership, Andrew Feldman, Atreides Management, Cerebras Systems, Fidelity Management, global AI adoption, high-performance AI, machine learning hardware, Nasdaq IPO, Nvidia competitor, positive AI news, private funding AI, Sunnyvale AI company, Tiger Global, U.S. IPO withdrawal, Valor Equity Partners

Cerebras Systems Pauses U.S. IPO Amid Strong Funding, Signals Confidence in AI Growth

AI chip pioneer Cerebras withdraws its U.S. IPO filing after a successful $1.1 billion funding round, highlighting strategic growth and